Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

被引：58

作者：

Fendler, Annika ^{[1
]}

Shepherd, Scott T. C. ^{[1
,14
,15
]}

Au, Lewis ^{[1
,14
,15
]}

Wu, Mary ^{[2
]}

Harvey, Ruth ^{[3
]}

Schmitt, Andreas M. ^{[14
,15
]}

Tippu, Zayd ^{[1
,14
,15
]}

Shum, Benjamin ^{[1
,14
,15
]}

Farag, Sheima ^{[14
,15
]}

Rogiers, Aljosja ^{[14
,15
]}

Carlyle, Eleanor ^{[14
,15
]}

Edmonds, Kim ^{[14
,15
]}

Del Rosario, Lyra ^{[14
,15
]}

Lingard, Karla ^{[14
,15
]}

Mangwende, Mary ^{[14
,15
]}

Holt, Lucy ^{[14
,15
]}

Ahmod, Hamid ^{[14
,15
]}

Korteweg, Justine ^{[14
,15
]}

Foley, Tara ^{[14
,15
]}

Barber, Taja ^{[1
]}

Emslie-Henry, Andrea ^{[1
]}

Caulfield-Lynch, Niamh ^{[1
]}

Byrne, Fiona ^{[1
]}

Deng, Daqi ^{[1
]}

Kjaer, Svend ^{[4
]}

Song, Ok-Ryul ^{[2
]}

Queval, Christophe ^{[2
]}

Kavanagh, Caitlin ^{[2
]}

Wall, Emma C. ^{[2
,23
]}

Carr, Edward J. ^{[5
]}

Caidan, Simon ^{[6
]}

Gavrielides, Mike ^{[7
]}

MacRae, James I. ^{[8
]}

Kelly, Gavin ^{[9
]}

Peat, Kema ^{[14
,15
]}

Kelly, Denise ^{[14
,15
]}

Murra, Aida ^{[14
,15
]}

Kelly, Kayleigh ^{[14
,15
]}

O'Flaherty, Molly ^{[14
,15
]}

Shea, Robyn L. ^{[16
,24
]}

Gardner, Gail ^{[16
]}

Murray, Darren ^{[16
]}

Yousaf, Nadia ^{[17
,18
]}

Jhanji, Shaman ^{[19
]}

Tatham, Kate ^{[19
]}

Cunningham, David ^{[20
]}

Van As, Nicholas ^{[21
]}

Young, Kate ^{[14
,15
]}

Furness, Andrew J. S. ^{[14
,15
]}

Pickering, Lisa ^{[14
,15
]}

机构：

[1] Francis Crick Inst, Canc Dynam Lab, London NW1 1AT, England

[2] Francis Crick Inst, High Throughput Screening Lab, London NW1 1AT, England

[3] Francis Crick Inst, Worldwide Influenza Ctr, London NW1 1AT, England

[4] Francis Crick Inst, Struct Biol Sci Technol Platform, London NW1 1AT, England

[5] Francis Crick Inst, Cell Biol Infect Lab, London NW1 1AT, England

[6] Francis Crick Inst, Safety Hlth & Sustainabil, London NW1 1AT, England

[7] Francis Crick Inst, Sci Comp Sci Technol Platform, London NW1 1AT, England

[8] Francis Crick Inst, Metabol Sci Technol Platform, London NW1 1AT, England

[9] Francis Crick Inst, Dept Bioinformat & Biostat, London NW1 1AT, England

[10] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London NW1 1AT, England

[11] Francis Crick Inst, Neurodegenerat Biol Lab, London NW1 1AT, England

[12] Francis Crick Inst, Struct Biol Dis Processes Lab, London NW1 1AT, England

[13] Francis Crick Inst, RNA Virus Replicat Lab, London NW1 1AT, England

[14] Royal Marsden NHS Fdn Trust, Skin Unit, London, England

[15] Royal Marsden NHS Fdn Trust, Renal Unit, London, England

[16] Royal Marsden NHS Fdn Trust, Dept Pathol, London, England

[17] Royal Marsden NHS Fdn Trust, Lung Unit, London, England

[18] Royal Marsden NHS Fdn Trust, Acute Oncol Serv, London, England

[19] Royal Marsden NHS Fdn Trust, Anaesthet Perioperat Med & Pain Dept, London, England

[20] Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, London, England

[21] Royal Marsden NHS Fdn Trust, Clincal Oncol Unit, London, England

[22] Royal Marsden NHS Fdn Trust, Haematooncol Unit, London, England

[23] Univ Coll London Hosp NHS Fdn Trust, Biomed Res Ctr, London, England

[24] Inst Canc Res, Translat Canc Biochem Lab, London, England

[25] Inst Canc Res, Melanoma & Kidney Canc Team, London, England

[26] UCL, Div Med, London, England

[27] UCL, Inst Canc, London, England

[28] UCL Queen Sq Inst Neurol, London, England

来源：

LANCET | 2022年 / 399卷 / 10328期

关键词：

D O I：

10.1016/S0140-6736(22)00147-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：905 / 907

页数：3

共 50 条

[21] Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients
Kanai, Daisuke
Wakui, Hiromichi
Haze, Tatsuya
Azushima, Kengo
Kinguchi, Sho
Kanaoka, Tomohiko
Toya, Yoshiyuki
Hirawa, Nobuhito
Kato, Hideaki
Uneda, Kazushi
Watanabe, Fumimasa
Hanaoka, Kanako
Hanaoka, Masaaki
Mitsuhashi, Hiroshi
Yamaguchi, Satoshi
Ohnishi, Toshimasa
Tamura, Kouichi
KIDNEY INTERNATIONAL REPORTS, 2022, 7 (12): : 2718 - 2721
[22] Boosting effects of additional mRNA COVID-19 vaccine given after one year in adults previously received two doses inactivated COVID-19 vaccines with third dose of any COVID-19 vaccine during Omicron XBB.1.5
Muangnoicharoen, Sant
Lawpoolsri, Saranath
Jongkaewwattana, Anan
Nanthapisal, Sira
Duangdee, Chatnapa
Kamolratanakul, Supitcha
Luvira, Viravarn
Thanthamnu, Narumon
Pitisuttithum, Punnee
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
[23] Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab
Madelon, Natacha
Heikkila, Nelli
Royo, Irene Sabater
Fontannaz, Paola
Breville, Gautier
Lauper, Kim
Goldstein, Rachel
Grifoni, Alba
Sette, Alessandro
Siegrist, Claire-Anne
Finckh, Axel
Lalive, Patrice H.
Didierlaurent, Arnaud M.
Eberhardt, Christiane S.
JAMA NEUROLOGY, 2022, 79 (04) : 399 - 404
[24] Subacute thyroiditis after the third dose of the COVID-19 mRNA vaccine. Case report
Frangos, Savvas
Haralambous, Haris
Michael, Kostas
Economides, Panayiotis A.
HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (02) : 210 - 212
[25] Sudden Sensorineural Hearing Loss after Third Dose Booster of COVID-19 Vaccine Administration
Zoccali, Federica
Cambria, Francesca
Colizza, Andrea
Ralli, Massimo
Greco, Antonio
de Vincentiis, Marco
Petrella, Carla
Fiore, Marco
Minni, Antonio
Barbato, Christian
DIAGNOSTICS, 2022, 12 (09)
[26] Cerebral venous sinus thrombosis after a third dose of mRNA COVID-19 vaccine in an adolescent
Mizuno, Shinsuke
Koyama, Junji
Horikawa, Shogo
Kishimoto, Kenji
Hasegawa, Daiichiro
Kosaka, Yoshiyuki
Kasai, Masashi
PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
[27] Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds
Mahase, Elisabeth
BMJ-BRITISH MEDICAL JOURNAL, 2021, 375 : n3011
[28] Neutralization antibody titer and change in 50% protection after the third dose of the COVID-19 vaccine
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
INDIAN JOURNAL OF PHARMACOLOGY, 2024, 56 (02) : 80 - 83
[29] Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds
Mahase, Elisabeth
BMJ-BRITISH MEDICAL JOURNAL, 2021, 375 : n2623
[30] Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine
Tissot, Noemie
Brunel, Anne-Sophie
Bozon, Fabienne
Rosolen, Beatrice
Chirouze, Catherine
Bouiller, Kevin
VACCINE, 2021, 39 (36) : 5087 - 5090

← 1 2 3 4 5 →